Yingyi Qin
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Pathology and Forensic Medicine top 10%
- Alcohol Consumption and Health Effects
- Tea Polyphenols and Effects
Papers in
-
- Lung Cancer Treatments and Mutations 6
- Lung Cancer Diagnosis and Treatment 4
- Epidemiology 14
- Liver Disease Diagnosis and Treatment 4
- Co-authors
- Jia He (30 shared papers)Yuhao Zhou (7 shared papers)Feifei Yu (5 shared papers)Xin Wei (4 shared papers)Chi Zhang (2 shared papers)Xiaofei Ye (5 shared papers)Jian Lu (3 shared papers)Xinji Zhang (9 shared papers)
- Journals
- PLoS ONE (4 papers)Frontiers in Cardiovascular Medicine (3 papers)Journal of Stroke and Cerebrovascular Diseases (2 papers)Frontiers in Medicine (2 papers)International Journal of Cancer (2 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Yingyi Qin
52 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Hepatology 120
- Pathology and Forensic Medicine 219
- Cancer Research 163
- Oncology 230
- Pulmonary and Respiratory Medicine 264
Countries citing papers authored by Yingyi Qin
This map shows the geographic impact of Yingyi Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingyi Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingyi Qin more than expected).
Fields of papers citing papers by Yingyi Qin
This network shows the impact of papers produced by Yingyi Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingyi Qin. The network helps show where Yingyi Qin may publish in the future.
Co-authors
The 25 scholars most cited alongside Yingyi Qin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 145 | |
| 2 | 2014 | 133 | |
| 3 | 2014 | 124 | |
| 4 | 2013 | 119 | |
| 5 | Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial Hit paper breakdown → | 2024 | 64 |
| 6 | 2013 | 63 | |
| 7 | 2011 | 61 | |
| 8 | 2011 | 52 | |
| 9 | 2011 | 49 | |
| 10 | 2014 | 31 | |
| 11 | 2022 | 31 | |
| 12 | 2014 | 30 | |
| 13 | 2020 | 28 | |
| 14 | 2014 | 27 | |
| 15 | 2020 | 25 | |
| 16 | 2017 | 22 | |
| 17 | 2014 | 21 | |
| 18 | 2022 | 18 | |
| 19 | 2014 | 17 | |
| 20 | 2021 | 16 |
About Yingyi Qin
Yingyi Qin is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology, Surgery, Cardiology and Cardiovascular Medicine and Oncology, having authored 59 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Lung Cancer Treatments and Mutations (6 papers), Cardiac, Anesthesia and Surgical Outcomes (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Chronic Kidney Disease and Diabetes (3 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Hepatology (120 citations), Pathology and Forensic Medicine (219 citations), Cancer Research (163 citations), Oncology (230 citations) and Pulmonary and Respiratory Medicine (264 citations). Yingyi Qin has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Jia He, Yuhao Zhou, Feifei Yu, Xin Wei, Chi Zhang, Xiaofei Ye, Jian Lu, Xinji Zhang, Cheng Wu and Xiao Zhang. Their work appears in journals such as PLoS ONE, Frontiers in Cardiovascular Medicine, Journal of Stroke and Cerebrovascular Diseases, Frontiers in Medicine and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.